metoclopramide has been researched along with Neoplasm Regression, Spontaneous in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Neoplasm Regression, Spontaneous: Disappearance of a neoplasm or neoplastic state without the intervention of therapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strauchen, JA | 1 |
| Moran, C | 1 |
| Goldsmith, M | 1 |
| Greenberg, M | 1 |
1 other study available for metoclopramide and Neoplasm Regression, Spontaneous
| Article | Year |
|---|---|
Spontaneous regression of gastric lymphoma.
Topics: Aged; Aged, 80 and over; Cimetidine; Diagnosis, Differential; Humans; Lymphoma; Male; Metoclopramide | 1987 |